Aimmune Therapeutics: 3Q Earnings Snapshot
BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Wednesday reported a loss of $64.5 million in its third quarter.
The Brisbane, California-based company said it had a loss of $1.03 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.01 per share.
Aimmune Therapeutics shares have increased 19% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $28.57, a drop of almost 6% in the last 12 months.